CL
Insider
Caligan Partners LP
DirectorCaligan Partners LP (Director) filed 1 Form 4 report as a reporting entity in the trailing twelve months (1 purchase, 0 sales), most often in Liquidia Corporation (LQDA). Across 1 priced purchase filing, the average 21-session return was +20.5% from execution and +18.4% from disclosure (delay-adjusted; derived). The largest single filing was $318K of LQDA (5,300 sh × $59.98, as filed), executed May 19. Data as of Nov 8 2026.
Add to watchlistReturn, ttmiAverage return per filing, trailing twelve months
+20.5%
avg across 1 priced filings
Delay-adjustediThe same average, entered at disclosure dates
+18.4%
same 1 filings, from disclosure
Filings, ttm
1
1 buys · 0 sells
Median delay
1d
execution → disclosure
Volume, ttmiDollar value disclosed in the trailing twelve months
$318K
shares × price, as filed
Last traded
May 19
Filed May 20
Median ADV $143.6M across their filed names
Open performance→Volume by month
Buys $318K
Sells $0
Shares × price, as filed · by filing month · past 24 months
Sectors filed on
Healthcare
1 filing
Sector per market data · by filing · past 12 months
Most traded names
LQDA
Liquidia Corporation
LQDA · 1 buy · 0 sells
1 filing
Recent filings
LQDAPURCHASE
Liquidia Corporation
View filing →
$318K5,300 sh × $59.98
Exec May 19
Filed May 20 · 8:51 PM ET